FindTrial
Sign In

The effect of intrauterine infusion of anti-inflammatory therapy on the clinical outcome of repeated pregnancy failure

The effect of intrauterine infusion of anti-inflammatory therapy on the clinical outcome of repeated pregnancy failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015269
Enrollment
Unknown
Registered
2018-03-19
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated failure of pregnancy

Interventions

Research Group:Intrauterine perfusion of dexamethasone
Control group:No intrauterine intrauterine perfusion

Sponsors

Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. older than 40 years of age; 2. at least 3 cycles of IVF transplantation or at least 4 pieces of high quality embryo transplantation, and no implantation; 3. Spontaneous abortion 2 or more times more than 2 times; 4. volunteer to accept and cooperate with the researchers.

Exclusion criteria

Exclusion criteria: 1. severe endometriosis; 2. endometrial polyps and submucous myoma; 3. intrauterine adhesions; 4. congenital or acquired uterine malformations; 5. chromosomal abnormalities; 6. endocrine diseases; 7. unable to cooperate or unwilling to cooperate with investigators.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rates;—

Countries

China

Contacts

Public ContactLimin WU

Center for Reproductive Medicine and Prenatal Diagnosis, Anhui Provincial Hospital affiliated to Anhui Medical University

wuliminma@126.com+86 13605601977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026